We believe companies, like people, have a lifecycle. In their infancy, companies are typically entrepreneurial ventures, powered by the visionary spirit and energy of a startup.

By adolescence, the most successful companies enjoy exponential growth and develop mature processes and management structures. Provided they do this effectively, companies can sustain a long and prosperous adulthood, turning in years of steady growth for investors. By the time the decline phase manifests itself, companies may find themselves hampered by internal bureaucracy, bloated org charts, regulation, saturated markets and declining profits.

In this series of videos, Frank Jennings, Portfolio Manager of Oppenheimer International Global Opportunities Fund, sat down with Art Steinmetz, Chairman, CEO and President of OppenheimerFunds to discuss the growth curve and his approach to identifying and investing in companies that are in their emerging growth stage.

Frank also shares why he believes investors should count on progress over time, and not focus on any short-term dips in the markets. In Frank’s view, if the American system can remain true to its historical DNA, the country should be wealthier a decade from now than it is today.

He even sheds light on what he believes investors need to know about his strategy. In Frank’s opinion, investors should view Oppenheimer Global Opportunities Fund as an investment that can provide significant upside potential to their portfolio, though it will require the patience to take a long view and a willingness to assume risk.

How PM Jennings selects countries and stocks to invest in

Frank notes that roughly half of the portfolio is invested in U.S. stocks and the rest invested throughout the global markets. Although he’s a U.S.-based investor, he says he’s traditionally invested about 50% of the Fund overseas, with funds invested in a variety of countries that includes Japan and Europe – noting Italy, Germany and Scandinavia among the more notable regions in the portfolio.

in terms of industries, he says that Oppenheimer Global Opportunities Fund is a technology-oriented portfolio, with big positions in medical companies that are developing cutting edge techniques for diagnosing and treating a variety of diseases, including cancer.

Fund Details and Performance Global Opportunities Fund View Fund performance Strategy Information Global Multi Cap Growth View Strategy Detail

Follow @OppFunds for more news and commentary.